These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33575350)

  • 1. Intratumoral STING Agonist Injection Combined with Irreversible Electroporation Delays Tumor Growth in a Model of Hepatocarcinoma.
    Lasarte-Cia A; Lozano T; Cano D; Martín-Otal C; Navarro F; Gorraiz M; Casares N; Vivas I; Lasarte JJ
    Biomed Res Int; 2021; 2021():8852233. PubMed ID: 33575350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Effect of Irreversible Electroporation in Combination with Poly-ICLC Adjuvant in Preclinical Models of Hepatocellular Carcinoma.
    Vivas I; Iribarren K; Lozano T; Cano D; Lasarte-Cia A; Chocarro S; Gorraiz M; Sarobe P; Hervás-Stubbs S; Bilbao JI; Casares N; Lasarte JJ
    J Vasc Interv Radiol; 2019 Jul; 30(7):1098-1105. PubMed ID: 31101416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irreversible electroporation induces CD8
    Dai Z; Wang Z; Lei K; Liao J; Peng Z; Lin M; Liang P; Yu J; Peng S; Chen S; Kuang M
    Cancer Lett; 2021 Apr; 503():1-10. PubMed ID: 33444692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible Electroporation versus Radiofrequency Ablation: A Comparison of Local and Systemic Effects in a Small-Animal Model.
    Bulvik BE; Rozenblum N; Gourevich S; Ahmed M; Andriyanov AV; Galun E; Goldberg SN
    Radiology; 2016 Aug; 280(2):413-24. PubMed ID: 27429143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
    Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
    Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible Electroporation Can Effectively Ablate Hepatocellular Carcinoma to Complete Pathologic Necrosis.
    Cheng RG; Bhattacharya R; Yeh MM; Padia SA
    J Vasc Interv Radiol; 2015 Aug; 26(8):1184-8. PubMed ID: 26119204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Irreversible electroporation: present and future in the treatment of hepatocellular carcinoma].
    Cano D; Lasarte JJ; Vivas I
    An Sist Sanit Navar; 2022 Nov; 45(3):. PubMed ID: 36413004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible Electroporation For Hepatocellular Carcinoma: Longer-Term Outcomes At A Single Centre.
    Freeman E; Cheung W; Kavnoudias H; Majeed A; Kemp W; Roberts SK
    Cardiovasc Intervent Radiol; 2021 Feb; 44(2):247-253. PubMed ID: 33051707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Safety and Efficacy of Irreversible Electroporation for Large Hepatocellular Carcinoma.
    Zeng J; Liu G; Li ZH; Yang Y; Fang G; Li RR; Xu KC; Niu L
    Technol Cancer Res Treat; 2017 Feb; 16(1):120-124. PubMed ID: 27837054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological effect of irreversible electroporation on hepatocellular carcinoma.
    Guo X; Du F; Liu Q; Guo Y; Wang Q; Huang W; Wang Z; Ding X; Wu Z
    BMC Cancer; 2021 Apr; 21(1):443. PubMed ID: 33882892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct roles but cooperative effect of TLR3/9 agonists and PD-1 blockade in converting the immunotolerant microenvironment of irreversible electroporation-ablated tumors.
    Babikr F; Wan J; Xu A; Wu Z; Ahmed S; Freywald A; Chibbar R; Wu Y; Moser M; Groot G; Zhang W; Zhang B; Xiang J
    Cell Mol Immunol; 2021 Dec; 18(12):2632-2647. PubMed ID: 34782757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer cells ablation with irreversible electroporation.
    Miller L; Leor J; Rubinsky B
    Technol Cancer Res Treat; 2005 Dec; 4(6):699-705. PubMed ID: 16292891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic response to tumor ablation with irreversible electroporation.
    Li X; Xu K; Li W; Qiu X; Ma B; Fan Q; Li Z
    PLoS One; 2012; 7(11):e48749. PubMed ID: 23139816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of SLC administration and Tregs depletion is an attractive strategy for targeting hepatocellular carcinoma.
    Chen L; Zhou S; Qin J; Hu H; Ma H; Liu B; Wang X; Ma J; Ye S; Zhong C; Zhou G; Liang C
    Mol Cancer; 2013 Dec; 12(1):153. PubMed ID: 24304581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Murine Pancreatic Cancer Model.
    Narayanan JSS; Ray P; Hayashi T; Whisenant TC; Vicente D; Carson DA; Miller AM; Schoenberger SP; White RR
    Cancer Immunol Res; 2019 Oct; 7(10):1714-1726. PubMed ID: 31409607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid dramatic alterations to the tumor microstructure in pancreatic cancer following irreversible electroporation ablation.
    Zhang Z; Li W; Procissi D; Tyler P; Omary RA; Larson AC
    Nanomedicine (Lond); 2014; 9(8):1181-92. PubMed ID: 24024571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
    Distelmaier M; Barabasch A; Heil P; Kraemer NA; Isfort P; Keil S; Kuhl CK; Bruners P
    Radiology; 2017 Dec; 285(3):1023-1031. PubMed ID: 28799842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment.
    Ohkuri T; Ghosh A; Kosaka A; Zhu J; Ikeura M; David M; Watkins SC; Sarkar SN; Okada H
    Cancer Immunol Res; 2014 Dec; 2(12):1199-208. PubMed ID: 25300859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible electroporation is a surgical ablation technique that enhances gene transfer.
    Au JT; Wong J; Mittra A; Carpenter S; Haddad D; Carson J; Jayaraman S; Monette S; Solomon SB; Ezell P; Fong Y
    Surgery; 2011 Sep; 150(3):474-9. PubMed ID: 21878233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Irreversible Electroporation Ablation as Adjunctive Treatment for Margin Enhancement: Safety and Efficacy.
    Simmerman E; Chung J; Lawson A; Kruse E
    J Surg Res; 2020 Feb; 246():260-268. PubMed ID: 31610354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.